Advertisement · 728 × 90
#
Hashtag
#PRGO
Advertisement · 728 × 90
Preview
Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations Launching New Operational Enhancement Program- Expected to Deliver Pre-Tax Annualized Savings of $80 million to $100 million. The rest of the business was down -1.6%, half of which stemmed from lower OTC contract manufacturing and the other half from soft total OTC category consumption, which was partially offset by market share gains. Diluted EPS: Reported...

#PRGO Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations

www.stocktitan.net/news/PRGO/perrigo-report...

0 0 0 0
Preview
Perrigo Company plc Declares Quarterly Dividend of $0.29 per Share Perrigo Company plc announces a quarterly dividend of $0.29 per share, payable on March 24, 2026. This reflects the company's commitment to returning value to shareholders.

Perrigo Company plc Declares Quarterly Dividend of $0.29 per Share #dividends #Ireland #Dublin #Perrigo_Company #PRGO

0 0 0 0
Preview
Investors Rally Against Perrigo Company plc Amid Securities Violations Allegations Perrigo Company faces a class action lawsuit for securities law violations. Investors encouraged to join the legal action as they suffer losses.

Investors Rally Against Perrigo Company plc Amid Securities Violations Allegations #United_States #Los_Angeles #DJS_Law_Group #Perrigo_Company #PRGO

0 0 0 0
Preview
Join the Class Action Against Perrigo Company: Important Information for Shareholders The Gross Law Firm urges Perrigo Company shareholders to join a class action lawsuit by registering before the January 16, 2026 deadline.

Join the Class Action Against Perrigo Company: Important Information for Shareholders #United_States #New_York #Gross_Law_Firm #Perrigo_Company #PRGO

0 0 0 0
Preview
Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations Net Sales: $1.04 billion, down 4.1% year-over-year as favorable currency translation was more than offset by organic net sales and the impact of divestitures and exited products. Organic Net Sales: Down due to -2.8% from businesses under strategic review. $80 million in the prior year. Adjusted Operating Income: $173 million, down $9 million, reflecting gross...

#PRGO Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations

www.stocktitan.net/news/PRGO/perrigo-report...

0 0 0 0
Perrigo Earnings Beat: 7.5% EPS Growth Despite Revenue Challenges, Management Confident on Full-Year Targets Perrigo delivers $0.57 EPS on $1.06B revenue, maintains full-year outlook despite market headwinds. See detailed segment performance and strategic updates.

#PRGO Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations

www.stocktitan.net/news/PRGO/perrigo-report...

0 0 0 0
Preview
Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million Perrigo (NYSE: PRGO) has announced an agreement to sell its Dermacosmetics branded business to KKR-managed Kairos Bidco AB for up to €327 million. The deal includes €300 million in upfront cash and up to €27 million in potential milestone payments tied to net sales performance over three years.The transaction, expected to close in Q1 2026, is part of Perrigo's 'Three-S' strategic plan to Stabilize, Streamline, and Strengthen the organization. The divested brands include ACO, Biodermal, Emolium, and Iwostin, which generated approximately €125 million in net sales and about 5% of Perrigo's 2024 adjusted operating income.Proceeds will be directed towards previously announced capital allocation priorities, including strengthening the company's balance sheet. The deal remains subject to regulatory approvals and works council consultation.

#PRGO #KKR Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million

www.stocktitan.net/news/PRGO/perrigo-announ...

0 0 0 0
Preview
Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance Perrigo (NYSE: PRGO), a leading provider of Consumer Self-Care Products, has announced a strategic organizational restructuring to optimize its global Category-Led, Market Activation Growth Model. The company is making key leadership changes, with Roberto Khoury appointed as EVP & Chief Commercial Officer to lead global market activation, while Triona Schmelter, EVP & President of Consumer Self-Care Americas (CSCA), will depart the organization.The reorganization aims to enhance agility, accelerate innovation, and drive sustainable growth as part of Perrigo's multi-year Stabilize, Streamline and Strengthen ('Three-S') plan. The company will centralize its global brand-building capabilities while maintaining market-empowered activation and commercial excellence. The restructuring will not impact Perrigo's full-year 2025 adjusted EPS guidance or reporting segments.The implementation will occur over the coming months, following all required legal consultation processes. The roles of EVP and President CSCI and EVP and President CSCA will be discontinued as part of this organizational alignment.

#PRGO Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance

www.stocktitan.net/news/PRGO/perrigo-announ...

0 0 0 0
Preview
Good Start® Perrigo (NYSE:PRGO), through its Good Start® | Dr. Brown's™ brand, has announced a nationwide giveaway contest starting July 1, 2025. The month-long contest will select 100 winners who will each receive a two-month supply of Gentle Pro™ baby formula along with Dr. Brown's products, valued at $516.49 per winner.Alongside the contest, the company is making a significant charitable contribution to Baby2Baby, donating over 4,000 cans of Gentle Pro™ formula plus Dr. Brown's products, supporting over 95,000 feedings with a total donation value exceeding $85,000. The combined contest and donation initiative has an approximate retail value of $139,071.The contest runs through July with winners to be announced by August 6th. Gentle Pro™, described as the company's closest formula to breastmilk, features gut-friendly probiotics and 100% whey proteins, designed for babies with sensitive tummies.

#PRGO Good Start® | Dr. Brown's™ Launches 30-Day "Gentle Baby Formula Giveaway Contest" with a Generous Donation to Baby2Baby

www.stocktitan.net/news/PRGO/good-start-dr-...

0 0 0 0
🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#HPQ, #CRCL, #Z, #PRGO, #MAX

#OptionFlow #OptionsTrading #Trading

0 0 0 0
🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected! PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #HPQ 30.0x
2. #CRCL 8.9x
3. #Z 6.3x
4. #PRGO 4.4x
5. #MAX 4.1x

#OptionFlow #OptionsTrading #Trading

0 0 0 0
Preview
Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations Perrigo (PRGO) reported Q1 2025 financial results showing mixed performance. Net sales declined 3.5% to $1.04 billion, primarily due to divested businesses and currency impacts. Despite the sales decline, the company demonstrated significant profitability improvements with adjusted operating income increasing 57.6% to $147 million and adjusted EPS growing 106.9% to $0.60. The company's infant formula business showed strong recovery with 16% growth in the Nutrition category. Gross margins expanded substantially, with adjusted gross margin increasing 440 basis points to 41.0%. Due to macroeconomic uncertainty, Perrigo widened its 2025 net sales growth outlook to 0-3% from 1-3%, but reaffirmed other financial targets, including adjusted EPS guidance. The company's 'Project Energize' efficiency program has achieved approximately $159 million in gross annual savings with $20 million reinvested.

#PRGO Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations

www.stocktitan.net/news/PRGO/perrigo-report...

0 0 0 0
Original post on seekingalpha.com

Trump’s medical tariffs could significantly hurt these European healthcare firms

seekingalpha.com/news/4426700-trumps-medi...

#mdt #nvs #prgo #bayry #rhhby #fms #jazz #ste #amrn […]

1 0 0 0
Preview
Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor Day Perrigo (NYSE: PRGO) unveiled its strategic 'Three-S' plan at its Virtual Investor Day, focusing on consumerizing, simplifying, and scaling its global self-care platform. The plan includes: Stabilizing Consumer Self-Care Americas store brand and infant formula businesses, Streamlining the global portfolio and operations, and Strengthening investments in key 'High-Grow' brands.The company announced its fiscal year 2025 targets, including: 1-3% all-in net sales growth, 2.5-4.5% organic net sales growth, ~40% adjusted gross margin, and adjusted EPS of $2.90-$3.10 (13-21% growth). For fiscal years 2025-2027, Perrigo targets organic net sales CAGR of 2.5-4.5%, adjusted gross margin expansion of 200-400 basis points, and net leverage reduction to less than 3x adjusted EBITDA by 2027.

#PRGO Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor Day

www.stocktitan.net/news/PRGO/perrigo-provid...

0 0 0 0
Preview
Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations Net sales of $1.14 billion declined 1.6%, as organic growth of 0.7% was more than offset by unfavorable impacts from divested businesses and exited product lines and currency translation of 2.3%. Organic 2 net sales increased 0.7%, as higher net sales in the Nutrition, Skin Care and Women's Health Categories more than offset previously disclosed lost...

#PRGO Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations

www.stocktitan.net/news/PRGO/perrigo-report...

0 0 0 0
Preview
First OTC Birth Control Pill Launches Major College Initiative with WNBA Stars Opill teams with WNBA and Black Women's Health Imperative for nationwide 'Level The Court' campaign, bringing reproductive health education to 15 colleges across restrictive states.

#PRGO Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnerships

www.stocktitan.net/news/PRGO/opill-extends-...

0 0 0 0
Preview
Perrigo Sets Stage for Major Strategic Update: Q4 Results and Investor Day Double Header Perrigo schedules Q4 2024 earnings release for February 27, followed by Virtual Investor Day on February 28. Key strategic updates expected for healthcare leader.

#PRGO Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day on February 28, 2025

www.stocktitan.net/news/PRGO/perrigo-to-rel...

0 0 0 0
Post image

🚨 Institutions #optionsvolume surge detected!

Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #FLEX 1688.0x
2. #BTI 284.4x
3. #SKYT 106.0x
4. #PRGO 32.6x
5. #WSC 20.4x

#OptionFlow #OptionsTrading #Trading

1 0 0 0
Post image

Сегодня торговал на фондовом рынке. Без сделок. В одну сделку выставил ордер на вход, но произошло проскальзывание и я не вошел, а акция сходила 4 к 1.

#pts_анализсделок #pts_обучениетрейдингу #трейдинг #trading #обучениетрейдингу #трейдингснуля #трейдингдляновичков #stocks #техническийанализ #PRGO

0 0 0 0